Entidades Vinculadas

logotipo SCIAS

The Hospital de Barcelona - SCIAS participated in the first phase IIa, multicentre studies to assess the safety and efficacy of bone regeneration of progenitor cells processed with the Aastrom Replicell bioreactor in atrophic pseudarthrosis.

Hospital Clinico Valladolid logo web ITRT Teknon

The Hospital Clínico Universitario de Valladolid is participating with ITRT in the phase IIb, multicentre clinical trial to assess the efficacy of osteoarthritis treatment using allogeneic mesenchymal stem cells processed by the Institute for Biology and Molecular Genetics (IBGM).

Hospital Universitario La Paz

The Orthopaedics and Traumatology Department of the Hospital Universitario La Paz of Madrid is conducting, with ITRT of Centro Médico Teknon, a multicentre clinical trial to assess pseudarthrosis treatment using cultivated adipose tissue-derived mesenchymal stem cells incorporated in a new biomaterial developed by Laboratorio SALVAT and HISTOCELL.

Laboratorio SALVAT

Laboratorio SALVAT is the Sponsor of the multicentre clinical trial in which both the ITRT of Centro Médico Teknon, and the Orthopaedics and Traumatology Department of Hospital Universitario La Paz of Madrid, are participating. The purpose of the study is to assess pseudarthrosis treatment using cultivated adipose tissue-derived mesenchymal stem cells, incorporated in a new biomaterial developed by HISTOCELL.

HISTOCELL

HISTOCELL is a biopharmaceutical company located in the Science Park of the University of the Basque Country (Universidad del País Vasco) in Vizcaya, which develops products for regenerative medicine.

It has designed a procedure that allows adipose tissue-derived mesenchymal stem cells to be incubated in a biomaterial, which can be used to treat difficult-to-treat bone damage such as pseudarthrosis. The efficacy of this procedure is the subject of the clinical trial sponsored by...

logotipo Hospital Hospitalet web ITRT

The Hospital Gral. de la Cruz Roja de l'Hospitalet, now run by Consorci Sanitari Integral, participated with ITRT in the first bone regeneration multicentre clinical trials in atrophic pseudarthrosis, which applied bone grafts comprising progenitor cells cultivated with the Aastrom Replicell bioreactor.

logo INEFC Lleida - ITRT

INEFC Lleida is participating in the phase III, multicentre clinical trial sponsored by ITRT to assess the efficacy of PRP treatment in "tennis leg" muscle injuries. Dr Xavier Peirau is acting as Principal Investigator at this site.

logotipo Aastrom web ITRT

Aastrom Biosciences is a biotechnology company based in Michigan in the USA, which developed the Aastrom Replicell System bioreactor to process cells obtained from bone marrow aspiration. By means of a fully-automated progenitor cell selection and culture process, it produces a cell product with high doses of mesenchymal progenitor cells and endothelial cells for regenerative medicine. In collaboration with the Blood and Tissue Bank (BST...